saccharin has been researched along with Atrial Fibrillation in 1 studies
Saccharin: Flavoring agent and non-nutritive sweetener.
saccharin : A 1,2-benzisothiazole having a keto-group at the 3-position and two oxo substituents at the 1-position. It is used as an artificial sweetening agent.
Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral and intravenous flecainide is recommended for cardioversion of atrial fibrillation." | 8.12 | Open-Label, Multicenter Study of Flecainide Acetate Oral Inhalation Solution for Acute Conversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus Rhythm. ( Aksoy, I; Al-Windy, N; Badings, E; Belardinelli, L; Camm, AJ; Crijns, HJGM; Elvan, A; Kowey, PR; Madhavapeddi, P; Ruskin, JN; Tuininga, YS; Van Gelder, IC, 2022) |
| "Oral and intravenous flecainide is recommended for cardioversion of atrial fibrillation." | 4.12 | Open-Label, Multicenter Study of Flecainide Acetate Oral Inhalation Solution for Acute Conversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus Rhythm. ( Aksoy, I; Al-Windy, N; Badings, E; Belardinelli, L; Camm, AJ; Crijns, HJGM; Elvan, A; Kowey, PR; Madhavapeddi, P; Ruskin, JN; Tuininga, YS; Van Gelder, IC, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crijns, HJGM | 1 |
| Elvan, A | 1 |
| Al-Windy, N | 1 |
| Tuininga, YS | 1 |
| Badings, E | 1 |
| Aksoy, I | 1 |
| Van Gelder, IC | 1 |
| Madhavapeddi, P | 1 |
| Camm, AJ | 1 |
| Kowey, PR | 1 |
| Ruskin, JN | 1 |
| Belardinelli, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Prospective Randomized Multicenter Study of Flecainide Acetate Oral Inhalation Solution in Single and Repeat Dose Regimens for Acute Conversion to Sinus Rhythm in Subjects With Recent Onset of Symptomatic Paroxysmal Atrial Fibrillation[NCT03539302] | Phase 2 | 170 participants (Actual) | Interventional | 2018-05-29 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for saccharin and Atrial Fibrillation
| Article | Year |
|---|---|
Open-Label, Multicenter Study of Flecainide Acetate Oral Inhalation Solution for Acute Conversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus Rhythm.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electric Countershock; Flecainide; Huma | 2022 |